Petrov Research Institute of Oncology / НИИ Онкологии им. Петрова
Research facility
Location:
St. Petersburg,
Russian Federation (RU)
ISNI: 0000000093410551
ROR: https://ror.org/01mfpjp46
Standardization of the Definition and Surgical Management of Splenic Flexure Carcinoma by an International Expert Consensus Using the Delphi Technique: Room for Improvement? (2023)
Benlice C, Parvaiz A, Baca B, Hohenberger W, Miskovic D, Stocchi L, Steele S, et al.
Journal article
Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor plus (HR plus ) metastatic breast cancer (MBC) who have previously received a taxane (2021)
O'Shaughnessy J, Schwartzberg L, Piccart M, Rugo HS, Yardley DA, Cortes J, Untch M, et al.
Conference contribution
КАК ИСПОЛЬЗОВАТЬ ШКАЛУ КАЙЗЕРА ДЛЯ ПРИНЯТИЯ ДИАГНОСТИЧЕСКИХ РЕШЕНИЙ ПРИ МУЛЬТИПАРАМЕТРИЧЕСКОЙ МРТ МОЛОЧНОЙ ЖЕЛЕЗЫ (2020)
Dietzel M, Mazo ML, Rozhkova NV, Kharuzhyk SA, Kuplevatskaya DI, Busko EA, Hodikan GK, Baltzer PA
Journal article
A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk (2018)
Lu Y, Beeghly-Fadiel A, Wu L, Guo X, Li B, Schildkraut JM, Im HK, et al.
Journal article
Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study (2017)
Higgins M, Curigliano G, Dieras V, Kuemmel S, Kunz G, Fasching P, Campone M, et al.
Journal article
Biphasic Squamoid Alveolar Renal Cell Carcinoma: A Distinctive Subtype of Papillary Renal Cell Carcinoma? (2016)
Hes O, Condom Mundo E, Peckova K, Lopez JI, Martinek P, Vanecek T, Falconieri G, et al.
Journal article
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis (2014)
Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, Bonnefoi H, et al.
Journal article